FBL and type 2 diabetes mellitus: In the T2DM group, out of 54 samples that showed significant binding against MG-Fib, 17 samples were highly significant (p < 0.0001), 13 samples were very significant (p < 0.001), and 24 samples were significant (p < 0.05).